News Releases
Cannabix Receives Notice of Allowance for Cannabis Drug Detection Device U.S. Patent
October 28, 2020
Vancouver, British Columbia, October 28, 2020 -- Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company or Cannabix”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, reports that it has received a notice of allowance from the United States Patent and Trademark Office (USPTO) for its 2015 licensed patent application, No. 14/689434 entitled, “Cannabis Drug Detection Device”. The Company and its patent attorneys have been vigorously pursuing this original patent application since its filing in the spring of 2015. It should be noted that a notice of allowance from the USPTO does not constitute a grant of patent.
The Company will report on future material developments regarding its “Cannabis Drug Detection Device” patent application in due course.
Disclaimer:
The information in these press releases is historical in nature, has not been updated, and is current only to the date indicated in the particular press release. This information may no longer be accurate and therefore you should not rely on the information contained in these press releases. To the extent permitted by law, Cannabix Technologies Inc. and its employees, agents and consultants exclude all liability for any loss or damage arising from the use of, or reliance on, any such information, whether or not caused by any negligent act or omission.
